Naperville, IL -- (SBWire) -- 08/01/2013 --Reportstack, provider of premium market research reports announces the addition of India Pharmaceuticals and Healthcare Report Q3 2013 market report to its offering
Despite slowing growth in the Indian pharmaceutical market in the first four months of 2013,
top domestic firms continued to see strong double-digit growth in the latest quarter, outperforming
multinational pharmaceutical firms. We maintain that the Indian government's cost concerns will continue
to hinder revenue growth for multinational pharmaceutical firms, benefiting the domestic industry. In
foreign markets, Indian pharmaceutical firms will have to be more vigilant with manufacturing practices or
risk suffering losses due to drug recalls.
Headline Expenditure Projections
Pharmaceuticals: INR840bn (US$15.7bn) in 2012 to INR926.1bn (US$17.0bn) in 2013; +10.3% in local
currency terms and +8.3% in US dollar terms. Forecast slightly downgraded from Q213 due to slower
growth in the first four months of 2013.

To view the table of contents for this market research report please visit
http://www.reportstack.com/product/138453/india-pharmaceuticals-and-healthcare-report-q3-2013.html

Contact:
Roger Campbell
contactus@reportstack.com
Naperville
Illinois
United States
Ph: 888-789-6604
###